Patent · US Active

Subcutaneous administration of anti-hepatitis B antibodies

US9657087B2 · kind B2 · utility

0Cited by

2References

3Claims

0Family size

Assignee

Omrix Biopharmaceuticals Ltd. · IL

Inventors

Orgad Laub · Tel Aviv-Yafo, IL
Nadav Orr · Mazkeret Batya, IL

Key dates

Filing date	Jun 17, 2014
Grant date	May 23, 2017
Priority date	—
Expiry date	Jun 17, 2034

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K2039/54
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present application relates to an immunoglobulin preparation comprising anti-hepatitis B antibodies for subcutaneous administration and to uses thereof, including methods for treating, preventing and/or reducing a disease, disorder or condition associated with hepatitis B virus.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.